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Objective. To review the literature on the effects of whole-body vibration therapy in patients with fibromyalgia. Design. Systematic
literature review. Patients. Patients with fibromyalgia.Methods. An electronic search of the literature in four medical databases was
performed to identify studies on whole-body vibration therapy that were published up to the 15th of January 2015. Results. Eight
articles satisfied the inclusion and exclusion criteria and were analysed. According to the Dutch CBO guidelines, all selected trials
had a B level of evidence. The main outcomes that were measured were balance, fatigue, disability index, health-related quality of
life, and pain.Whole-body vibration appeared to improve the outcomes, especially balance and disability index.Conclusion.Whole-
body vibration could be an adequate treatment for fibromyalgia as a main therapy or added to a physical exercise programme as it
could improve balance, disability index, health-related quality of life, fatigue, and pain. However, this conclusion must be treated
with caution because the paucity of trials and the marked differences between existing trials in terms of protocol, intervention, and
measurement tools hampered the comparison of the trials.
1. Introduction
Fibromyalgia (FM) is a chronic disorder of unknown aetiol-
ogy. It is characterised by widespread noninflammatory pain
and tenderness that persists for at least 3 months and by an
acute response in at least 11 of 18 specified tender points when
these points are digitally palpated with a pressure of 4 kg/cm2
[1]. FM is associated with several symptoms, including
fatigue, disrupted sleep, impaired cognition, poor physical
fitness, headaches, arthritis, muscle spasm, tingling, and bal-
ance problems [2, 3]. These symptoms reduce the health-
related quality of life (HRQoL) of people with FM [4].
In European populations (Spain, Portugal, France, Ger-
many, and Italy), the estimated overall prevalence of FM
is between 2.9% and 4.7% [5]. Consequently, this disorder
imposes a significant economic burden due to healthcare
costs and the inability of the patients to work [6]. In fact, FM
accounts for 4–20% of all new patient contacts in primary
care settings [7].
Several therapies have been used to treat the symptoms
associated with FM, including pharmacological and non-
pharmacological therapies. There is strong evidence show-
ing that both pharmacological and nonpharmacological
approaches can be effective [8]. Nonpharmacological thera-
pies include physical therapies such as yoga, tai chi, walking,
and whole-body vibration (WBV) [9]. WBV is a physical
therapy thatwas shown to improvemuscle strength [10], body
balance [11], gait mobility [12], cardiorespiratory fitness [13],
bone-density [14], and pain [15] in healthy and various clin-
ical populations.
WBV can be delivered by two types of exercise platform.
One is a sinusoidal vibration device that induces reciprocal
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vertical displacements on the left and right sides of a fulcrum
and generates higher lateral acceleration than vertical accel-
eration.The second is a vertical vibration device that induces
up-and-down oscillations over a vertical axis and produces
high strain in the vertical axis [16]. The intensity of vibration
is determined by three parameters [17], namely, amplitude,
frequency, and oscillation acceleration.
Some studies suggested that WBV therapy may improve
balance, pain, and fatigue. The mechanisms behind these
effects are not clear but may relate to the following.
(1) WBV elevates heart rate and oxygen uptake, which
could translate to improved cardiorespiratory fitness
over the long term [18].
(2) WBV may influence the neuromuscular system and
improve reflex responses, especially in patients who
have altered reflex generation. This may be related to
the ability of vibration to (a) stimulate subcutaneous
proprioceptors, (b) activate muscle spindles, thereby
causing muscle contraction, and (c) stimulate Golgi
tendon organs, thereby improving tonic and antago-
nist vibration reflexes [19]. WBV may also promote
adaptation of human cutaneous sensors in the sole of
the foot [20].
(3) WBV may reduce the perception of pain because
vibration affects the afferent discharge of fast adapting
mechanoreceptors and muscle spindles [21].
Potential harmful effects of vibration exposure have been
found in industrial workers, and vibration is recognised as an
industrial hazard. Prolonged exposures can induce vascular
and neurological injuries, and legal limits have been set in
numerous countries [22].Therefore, any training protocol has
to maximize the potential benefits while reducing the poten-
tial adverse side effects. To our knowledge, WBV-related
adverse effects have not been reported in any studies that
focused on FM.
To our knowledge, there is one review that examined
the effect of WBV therapy on FM-associated symptoms [23].
However, this review only examined three articles, all of
which were published between 2008 and 2010. Another five
articles on WBV therapy in FM have been published ever
since. The aim of the present review was to provide an up-
to-date analysis of the research on the effect of WBV on
FM-associated symptoms, including poor balance, fatigue,
pain, and poorHRQoL.The ultimate objective was to provide
future directions in clinical practice.
2. Materials and Methods
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) methodology was employed to carry out
this systematic review [24].
2.1. Electronic Database Searches andArticle Selection Strategy.
To locate the articles reported in this systematic review,
four well-known electronic databases were selected, and a
list of terms and compounded terms was prepared. These
activities were supervised by medical library science experts
Potential studies identified
(i) Clearly not meeting inclusion 
Articles analysed in more 
Not a randomised controlled 
Articles selected and 
(n = 68)
Excluded (n = 57)
criteria (n = 33)
(ii) Duplicated (n = 24)
detailed (n = 11)
Excluded (n = 3)
trial (n = 3)
analysed (n = 8)
Figure 1: Flow chart delineating the complete systematic review
process that was followed.
and experts in the field of WBV in FM. The databases were
the Cochrane Library (2003–present), the Physiotherapy
Evidence Database (PEDro; 2003–present), PubMed (1973–
present), and TRIP (2002–present). The articles were located
using the keywords “fibromyalgia” and “vibration” and the
Boolean operator “AND”. Duplicate articles were manually
removed by one of the authors.
Figure 1 shows a flow chart delineating the complete sys-
tematic review process. The articles were indexed according
to whether they met all of the following inclusion criteria: (a)
the study focused onWBV therapy, (b) the study cohort only
consisted of people with FM, (c) the study was a randomised
controlled trial (RCT), (d) the whole publication was written
in English, and (e) the article was an original clinical study.
Studies were excluded if theymet any of the following criteria:
(a) the study examined the effects of exposure to vibration
within industry or employment of labour and transport and
(b) the study was only presented once as a summary at a
conference, congress, or seminar. The articles were selected
by two independent experts. Disagreements were resolved
through group discussions until a mutual consensus was
reached.The search was finalized on the 15th of January 2015,
with no submission deadline being imposed.
2.2. Assessing the Risk of Bias. The PEDro scale was used to
assess the risk of bias in the selected articles.This is a scale that
rates the methodological quality of RCTs that evaluate phys-
ical therapist interventions. This scale was chosen because of
its special design and capacity to provide a global overview
of the external and internal validity of the studies [25]. Each
article was graded by one of the authors, and this grading was
supervised by another author with experience in this task.
Table 1 shows the consensus results for each article.
2.3. Determining the Level of Evidence. The level of evidence
was determined using the guidelines of the Dutch Institute
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Table 1: Risk of bias and level of evidence.
Clinical trial Reference Response to each item on the PEDro scale Level of evidence
1 2 3 4 5 6 7 8 9 10 11 Total score
Alentorn-Geli et al. [29] y y n y y n y y n y Y 7 B
[27] y y n y y n n y n y Y 6 B
Gusi et al.
[30] y y y y n n y y y y Y 8 B
[31] y y y y n n y y y y Y 8 B
[32] y y y y n n y y n y Y 7 B
San˜udo et al. [33] y y y y n n n y n y Y 6 B
[34] y y y y n n n y n y Y 6 B
San˜udo et al. [28] y y y y n n n y y y Y 7 B
n: criterion not fulfilled; y: criterion fulfilled; 1: eligibility criteria were specified; 2: subjects were randomly allocated to groups or to a treatment order; 3:
allocation was concealed; 4: the groups were similar at baseline; 5: there was blinding of all subjects; 6: there was blinding of all therapists; 7: there was blinding
of all assessors; 8: measures of at least one key outcomewere obtained frommore than 85% of the subjects whowere initially allocated to groups; 9: intention-to-
treat analysis was performed on all subjects who received the treatment or control condition as allocated; 10: the results of between-group statistical comparisons
are reported for at least one key outcome; 11: the study provides both point measures and measures of variability for at least one key outcome; total score: each
satisfied item (except the first) contributes 1 point to the total score, yielding a PEDro scale score that can range from 0 to 10. B: the level of evidence was B
(randomised control trials that lacked double-blinding) (see the Appendix).
for Healthcare Improvement (CBO) [26]. Table 1 shows the
results.
2.4. Data Extraction and the Main Measurements Examined.
Data were extracted from the selected articles by one of
the authors. This extraction was checked by another author.
Any disagreement was discussed and ultimately resolved by
a third author if the contact with the original author of the
article could not be established.
For each selected article, the following data were
extracted: (a) the sample and protocol characteristics, namely,
the sample size, age, and activity of the control and WBV
groups (Table 2) and (b) the vibration therapy details, namely,
the type of device and its oscillation acceleration, frequency,
and amplitude; the duration of the intervention; the number
of WBV sessions; and the number of vibration series, the rest
period, and the exposure duration in each series (Table 3).
3. Results
3.1. Article Selection. Figure 1 depicts the process that was
followed in this systematic review. In total, 68 articles were
found in the electronic search of the Cochrane Library (11
articles), PubMed (24 articles), Trip (25 articles), and PEDro
(eight articles). After removing the duplicates, 44 references
were reviewed. Of these, 33 were excluded because a review of
their summaries revealed that the study clearly did not meet
the inclusion criteria. The remaining 11 articles were then
analysed in more depth to determine whether they satisfied
the inclusion and exclusion criteria. This led to the exclusion
of three articles because they were not RCTs. Finally, eight
articles belonging to four different trials were included in our
systematic review.
3.2. Risk of Bias. Table 1 shows the risk of bias of each of the
four RCTs, as indicated by the PEDro scale score. All 8 articles
were on RCTs because this was an inclusion criterion. The
PEDro scale score ranged from 6 to 8 points (the maximum
score was 10 points). The average (SD) score was 6.88 (0.83).
The poorest scores were obtained for questions five (“there
was blinding of all subjects”), six (“there was blinding of all
therapists”; this reflects the fact that it is difficult to blind a
WBV therapist), and nine (“intention-to-treat analysis was
performed on all subjects who received the treatment or con-
trol condition as allocated”). Good scores were obtained for
questions one (“eligibility criteria were specified”), two (“sub-
jects were randomly allocated to groups or to a treatment
order”), four (“the groups were similar at baseline”), eight
(“measures of at least one key outcome were obtained from
more than 85% of the subjects initially allocated to groups”),
10 (“the results of between-group statistical comparisons are
reported for at least one key outcome”), and 11 (“the study
provides both point measures and measures of variability for
at least one key outcome”).
3.3. Level of Evidence. Table 1 also indicates the level of evi-
dence in each study. All eight articles had a B level of evidence
because; although every article reported the results of an
RCT, none of these RCTs was double-blind. Table 4 shows the
level of conclusion according to the Dutch CBO guidelines
(in the appendix). The score ranged from 2 to 3 because
only four different RCTs were reviewed, all of which had a
B level of evidence.
3.4. Study Characteristics. Tables 2, 3, and 5 summarize the
study characteristics using the PICOS (Patients, Intervention,
Control, Outcomes, and Study design) approach [24]. All
four RCTs were performed with adult and elderly women
with FM, and the sample size varied from 24 [27] to 46 [28]
participants.
3.5. WBV Equipment. Two RCTs used the Power Plate
vibratory platform [27–29], and the other two RCTs used
the Galileo vibratory platform [30–34]. The Galileo plat-
form produces a horizontal sine-wave vibration, whereas the
Power Plate platform produces a vertical sine-wave vibration
(Figure 2).
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Table 3: WBV therapy and activity.
Authors Freq.(Hz)
Amp.
(mm)
Vibration
device
Type of
vibration
Duration
(weeks)
Number
of sessions Number of series Time series (s)
Rest between
series (s)
Alentorn-Geli
et al. [27, 29] 30 2
Power
Plate
Vertical
sine wave 6 12
Three in the first two sessions
Six in the last nine sessions 30 180
Gusi et al.
[30–32] 12.5 3 Galileo
Horizontal
sine wave 12 36 6
30 s in sessions 1–4
45 s in sessions 5–8
60 s in sessions 9–12
60
San˜udo et al.
[33, 34] 20
3*
2** Galileo
Horizontal
sine wave 6 18
3*
4**
45*
30** 120
San˜udo et al.
[28] 30 4
Power
Plate
Vertical
sine wave 8 24
6*
4**
30*
60** 45
Freq.: frequency; Amp.: amplitude.
*With both feet in contact with the platform; **With one foot in contact with the platform.
Table 4: Level of conclusion according to the Dutch CBO guide-
lines.
Outcome measure Level ofconclusion
Balance 2
Quality of life 2
Serum insulin-like growth factor-1 3
Strength 3
Fatigue 2
Pain 3
Depression 3
Stiffness 3
Disability index (fibromyalgia impact questionnaire) 2
CBO: Institute for Healthcare Improvement.
Level 2: one trial of level A2 or at least two independent trials of level B (see
the Appendix); 3: one trial of level B or C (see the Appendix).
3.6. WBV Parameters
3.6.1. Frequency and Amplitude. The four RCTs differed in
terms of the amplitude and frequency of the vibration.
The two RCTs that used the horizontal sine-wave vibration
employed an amplitude of 2-3mm and a frequency of 12.5–
20Hz, and the two RCTs that used the vertical sine-wave
vibration employed an amplitude of 2–4mm and a frequency
of 30Hz.
3.6.2. Performance on the Platform. The postures used in the
four RCTs also varied. In three RCTs, patients maintained
a static posture on the platform during vibration [28, 30–
34], whereas, in the fourth RCT, patients performed both
static and dynamic tasks during vibration [27, 29]. In two
RCTs, both feet were always on the platform during vibration
[27, 29–32], and, in the other two RCTs, some series were
performedwith only one foot on the platform [28, 33, 34].The
knee angle varied between 45∘ and 130∘ in the two static-task
RCTs and between 90∘ and 180∘ in the dynamic-and-static-
task RCT.
Figure 2: Power Plate and Galileo vibration platforms.
3.6.3. Description of Training. All four RCTs sought to anal-
yse the long-term effects of WBV therapy. In two of the three
RCTs, 6 weeks of WBV therapy were performed [27, 29, 33,
34]. The authors of the first RCT [27, 29] chose this duration
because, although it would be inadequate for a traditional
exercise program, it should be sufficient for the develop-
ment of WBV-induced adaptations that would improve pain,
fatigue, stiffness, and depression in patients with FM. The
Gusi et al. RCT had the longest WBV therapy, which con-
sisted of 36 sessions over 12 weeks [30–32]. The number of
series ranged from three to ten, and each lasted between 30 s
and 60 s with a rest interval of 45–180 s (Table 3).
3.7. Key Measurements and Effects. The measurements with
the highest level of conclusion (Table 4) were balance,
HRQoL, fatigue, and disability assessed using the fibromyal-
gia impact questionnaire (FIQ) [35]. The level of conclusion
for pain was lower than that for the other measures, but
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because pain is a main symptom of FM, it was analysed
independently.
3.7.1. Balance. Three of the RCTs [28, 30–34] evaluated the
effects of WBV therapy on balance, specifically dynamic
balance and static balance. One of these RCTs analysed static
balance with both open and closed eyes. All three RCTs used
a Biodex Balance System to measure balance. This device
measures the tilt about each axis during dynamic conditions
and calculates a mediolateral stability index, an anteropos-
terior stability index, and an overall stability index [36].
These indices are SDs that assess fluctuations around a zero
point that is established prior to testing when the platform
is stable (rather than around the group mean). A lower score
indicates better balance.
One study showed that WBV significantly improved the
dynamic balance of the WBV group compared to the control
group [30]. In three studies, mediolateral and anteroposterior
indices were both measured, but, in two studies, only the
mediolateral stability index improved [28, 34], and, in the
other study, only the anteroposterior stability index improved
[32].
3.7.2. Quality of Life. Two studies assessed HRQoL [31, 33]
using the global score of the 36-Item Short Form Health Sur-
vey (SF-36, Medical Outcome Study) [33] or the 15D© ques-
tionnaire [31]. Both questionnaires are not specifically devel-
oped for FM. The 15D© questionnaire assesses 15 HRQoL
dimensions, namely, moving, seeing, hearing, breathing,
sleeping, eating, speech, eliminating, usual activities, mental
function, discomfort and symptoms, depression, distress,
vitality, and sexual activity [37]. The SF-36 is a well-known
questionnaire that assesses limitations, bodily pain, vitality,
mental health, and general health perception [38]. Significant
improvement in SF-36 score [33] was reported, but not in the
15D© [31].
3.7.3. Fatigue. Three of the RCTs assessed the effect of WBV
therapy on fatigue [28, 29, 33]. Several different measures of
fatigue were used: the number of repetitions of half squat
performed in 60 s; a fatigue index, expressed as the decline in
the peak torque from the start of the half squat exercise (first
five repetitions) to the end of the exercise (last five repeti-
tions); and the 100mm visual analogue scale contained in the
FIQ.
In one study, WBV improved fatigue relative to both
baseline and the control group [29]. In another study, WBV
improved the number of repetitions relative to baseline [33].
In the third study, WBV did not have a significant effect on
fatigue [28].
3.7.4. Disability Index. The disability caused by FM was
assessed in three RCTs using the Spanish version of the
FIQ [39]. One study [31] used this questionnaire to evaluate
HRQoL. However, the FIQ is an instrument that assesses the
effect of FM symptoms on health status and the disability
index and does not measure HRQoL [40].
In one RCT [30–32], the WBV-treated patients exhib-
ited a significant improvement in FIQ score relative to
the untreated control patients. In the other two RCTs [27,
29, 33, 34], patients undergoingWBVduring traditional exer-
cises showed significant improvements in FIQ score relative
to baseline. However, there were no statistically significant
differences between the traditional exercise − only group
and the exercise + vibration group.
3.7.5. Pain. Pain is themost important symptom in FM, but it
was assessed specifically in only one study, which reported an
improvement in pain compared to both baseline and the con-
trol groups [29]. However, pain is part of the FIQ and 15D©
questionnaires that were used to evaluate HRQoL in two of
the other RCTs [31, 33].
4. Discussion
The four RCTs revealed that WBV therapy may improve
several symptoms of FM, namely, disability, pain, poor
HRQoL, poor balance, and fatigue.
The duration of the treatment could be extremely relevant
when assessing the effects of WBV on disability caused by
FM. Two RCTs only involved 6 weeks of complementary
vibration therapy, and oneRCT involved 12weeks of vibration
therapy. This latter RCT reported a significant improvement
in FIQ score relative to the control group, whereas the other
two RCTs only reported within-group improvements. It may
be that the effect of WBV therapy on FIQ score can only be
observed with longer treatments.
With regard to pain, the single study examining this
outcome used the 100mm VAS to show that WBV therapy
significantly improved pain compared to both baseline and
the control groups [29]. However, the level of conclusion for
this measure was 3, which is low. Pain is also a subscale of the
FIQ. Three articles assessed the effects of vibration on total
FIQ score, but they did not report the changes in this dimen-
sion. In patients with chronic back pain, evidence suggests
that vibration could alleviate pain [41, 42]. The mechanism
by which WBV could reduce pain perception was discussed
widely in a previous review [21]. However, it is possible that
the mechanisms that lead to a reduction of pain in diseases
characterised by local pain do not work in FM patients,
because FM is characterised by widespread pain, and the
cause of pain is likely to be different. Because pain is one of the
main symptoms of FM, additional studies that assess the
effects of WBV on pain in FM are needed.
There were large differences in treatment effects on bal-
ance. These discrepancies may reflect differences between
the WBV protocols. Effects of the two vibratory platforms
(Galileo and Power Plate) on balance were compared by
San˜udo et al. [28, 33, 34], who reported that the mediolateral
stability indexwas improved by both theGalileo platform and
the Power Plate platform. However, in the study of Adsuar et
al., which used the Galileo platform, only the anteroposterior
stability index improved [32]. Given that mediolateral sway
is more correlated with fall risk [43], the protocol of San˜udo
et al. may be better at preventing falls.
With regard to fatigue, San˜udo et al. compared the two
vibratory platforms with the same protocol. They found that
only the Galileo platform induced a significant improvement
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in the number of repetitions of a half squat exercise per-
formed in 60 s. However, it cannot be concluded that these
improvements were due to an improvement in cardiorespi-
ratory fitness. Devices that assess oxygen consumption in a
more objective way must be used to evaluate this measure.
Three RCTs yielded five articles [27–29, 33, 34] that
showed that when WBV therapy complemented a physical
exercise programme, there were significant improvements
in muscle performance (increased strength and decreased
fatigue) or balance that were larger and more significant than
the improvements obtained by standard exercise (Table 5).
Thus, adding WBV can enhance the benefits of a physical
exercise programme. Given that WBV only requires a few
minutes to be delivered, it could be a good complement to
usual physical exercise protocols.
The differences between studies in the effect of WBV
on balance [28, 32, 34], fatigue [28, 29, 33], and FIQ score
[29, 31, 33] could be attributed to differences in the baseline
scores or differences in the vibration protocols in terms of
the type of vibration, the duration of treatment, and the rest
intervals. The disparities could also reflect differences in the
instrument that was used in the evaluation. In support of this,
the baseline FIQ scores in the San˜udo et al. andAlentorn-Geli
et al. studies differ by almost 28%; thus, it can be expected that
these studies will differ in the degree of improvement that
is observed. Other variables should be considered to better
explain these differences, including the weather [44], patient
weight [45], and patient age, whichmay be a surrogatemarker
of the effect of menopause on women with FM [46].
The four RCTs differed markedly in terms of important
characteristics, namely, the type of vibration (vertical or hor-
izontal sine wave), the type of therapy (vibration or exercise +
vibration), and the vibration protocol (frequency, amplitude,
time series, rest interval, and duration).Therefore, additional
studies that assess the effect of WBV in different settings are
needed. These studies should compare (a) different protocols
with the same device and the same type of therapy, (b)
different devices with a similar protocol and the same type
of therapy, and (c) different types of therapies with the same
device and the same protocol. These studies will identify the
optimal characteristics of vibration therapy that are needed to
improve functional capacity, HRQoL, balance, and other key
symptoms of FM.
To our knowledge, the acute effects ofWBVon FM symp-
toms have not been assessed by any study. However, a study
on patients with low back pain showed that a singleWBV ses-
sion induced statistically significant within-group changes in
lumbopelvic pain perception [47]. Another study on patients
with low back pain reported that WBV therapy induced a
greater reduction in pain after 12 months than after 6 months
[42]. This suggests that the duration of WBV in the RCTs
analysed in this study (6–12 weeks) was too short to signifi-
cantly reduce pain.Therefore, additional trials that assess the
effects of both short- and long-term (6–12 months) WBV
therapy on FM-associated pain are needed. Studies that
examine the effects of long-termWBV therapy on balance are
also needed because several studies showed that long WBV
treatments (6–12 months) significantly improved postural
control and static and dynamic balance in populations that
share some of the characteristics of patients with FM (i.e.,
postmenopausal or elderly women) [48–50].
The present systematic review only identified a limited
number of studies on the effects of WBV therapy on FM.
This reflects the fact that the RCTs on this issue only started
very recently; the first completed studywas published in 2008.
The small number of trials together with their wide varia-
tion in terms of PICOS (Participants, Intervention, Control,
Outcome Measurements, and Study design) hampers meta-
analysis.This explains why the CBO guidelines [26] indicated
that the level of conclusion regarding the effect of WBV
therapy on FM was 3.
There are several limitations that should be considered.
First, standardised criteria to assess the level of evidence are
needed. Authors of systematic reviews often use different
criteria [51] that depend on the methodological quality (i.e.,
RCT versus low-quality trials) of the analysed studies. The
scales of measurement may vary across the criteria, and the
best method for assessing the risk of bias is not clear [51].
However, only RCTs were considered in the current system-
atic review. Second, some bias may have been introduced
because the search strategy omitted articles in languages
other than English. Significant results are easier to publish
than nonsignificant results and, consequently, the latter are
more likely to appear in national journals that are written in
a native language [52]. WBV dose-response analysis was not
included because of the variability among devices and proto-
cols, and the few available references in FM patients.
As emphasised in the Introduction, FMentails a huge cost
to governments. Therefore, studies on the cost-effectiveness
and utility of WBV as a therapy in a condition that is as
prevalent and widespread as FM are needed.
5. Conclusions
WBVmay be an adequate treatment for FM as amain therapy
or when added to a physical exercise programme as it could
improve the balance, disability index, quality of life, fatigue,
and pain of patients with FM. However, the small number
of RCTs on WBV in FM and their wide variation in terms
of vibration protocol, intervention, and measurements ham-
pered our comparison of these trials. Additional studies that
definitively clarify the effects of WBV therapy on FM are
needed.
Appendix
Levels of Evidence and Conclusion according
to the Dutch CBO Guidelines
Levels of Evidence according to the Dutch CBO Guidelines
A1: systematic review containing at least two independent
trials of level A2;
A2: randomised comparative double-blind study of good
quality and sufficient size;
B: comparative trials, but not all characteristics of A2
(also, patient control studies and cohort studies);
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C: noncomparative trials;
D: expert opinion.
Level of Conclusion according to the Dutch CBO Guidelines.
Conclusion is based on the following:
(1) research on level A1 of at least two independent trials
of level A2;
(2) one trial of level A2 or at least two independent trials
of level B;
(3) one trial of level B or C;
(4) expert opinion.
CBO: Institute for Healthcare Improvement.
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